文献速递心外重症与机械循环支持

心脏移植桥接策略的移植后结局:韩国全国多中心研究

Post-transplant outcomes by bridging strategy: A nationwide multicenter study of heart transplant recipients in Korea.
PubMed 文献 · J Heart Lung Transplant · 2025-10-06

该研究回顾性分析韩国器官移植登记处2014至2023年1021例成人心脏移植受者,比较ECMO、LVAD及非机械循环支持桥接者的移植后结局。ECMO桥接与严重原发性移植物功能障碍及早期死亡风险显著升高相关,而LVAD桥接结局与非MCS相当。

要点

  • ECMO桥接者严重PGD风险显著高于非MCS(校正HR 3.68)和LVAD(校正HR 2.23)。
  • ECMO组住院死亡率17.9%,高于LVAD组和非MCS组的4.4%。
  • 6个月标志性分析显示三组生存率相似,早期死亡驱动ECMO组劣势。

核心结论

  • 直接ECMO桥接与较差的早期移植后结局相关,主要由严重PGD和早期死亡驱动,需谨慎选择候选者。
  • LVAD桥接提供了与非MCS相当的结局,可能为部分ECMO患者提供桥接至候选的策略。

研究设计与样本

  • 回顾性分析韩国器官移植登记处2014至2023年1021例成人心脏移植受者。
  • 按移植时桥接策略分为ECMO组357例、LVAD组137例和非MCS组527例。

主要发现

  • ECMO桥接与严重PGD风险显著升高相关(校正HR 3.68 vs 非MCS;2.23 vs LVAD)。
  • 住院死亡率ECMO组17.9%,LVAD组4.4%,非MCS组4.4%(P < 0.001)。
  • Kaplan-Meier分析显示ECMO组90天生存率83.2% vs 94.8% vs 95.0%,1年生存率77.5% vs 89.0% vs 92.5%(log-rank p < 0.0001)。
  • 6个月标志性分析中三组生存率相似。
  • ECMO组中6个月内死亡者移植前透析比例显著更高(66.7% vs 34.7%,p < 0.001)。

临床怎么用

  • ECMO桥接患者移植后需警惕严重PGD和早期死亡风险,加强围术期管理。
  • 对部分ECMO患者可考虑LVAD桥接至候选策略以改善移植后结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is prioritized in Korea's heart transplant (HTx) allocation system to reduce waitlist mortality, but post-transplant outcomes remain a concern. We compared post-transplant outcomes among HTx recipients bridged with ECMO, left ventricular assist device (LVAD), or without mechanical circulatory support (non-MCS). METHODS: We retrospectively analyzed 1021 adult HTx recipients enrolled in the Korean Organ Transplant Registry (2014-2023). Patients were categorized according to bridging strategy at transplantation (ECMO n = 357, LVAD n = 137, non-MCS n = 527). Outcomes included primary graft dysfunction (PGD), in-hospital mortality, any treated rejection, coronary allograft vasculopathy, infection requiring hospitalization, and post-transplant mortality. RESULTS: ECMO bridging was associated with significantly higher risks of severe PGD (adjusted HR 3.68 vs non-MCS; 2.23 vs LVAD). In-hospital mortality was highest in ECMO recipients (17.9%) compared with LVAD-bridged (4.4%) and non-MCS recipients (4.4%) (P < 0.001). Kaplan-Meier analysis demonstrated significantly lower survival in the ECMO group at 90 days (83.2% vs 94.8% vs 95.0%) and 1 year (77.5% vs 89.0% vs 92.5%) (log-rank p < 0.0001). However, in 6-month landmark analyses, survival was similar across groups. Among ECMO recipients, those who died within 6 months had a markedly higher prevalence of pre-transplant dialysis (66.7% vs 34.7%, p < 0.001). The incidence of treated rejection and CAV did not differ significantly among the three groups. CONCLUSIONS: Direct ECMO bridging is associated with worse early post-transplant outcomes, primarily driven by severe PGD and early mortality, underscoring the need for careful candidate selection. LVAD bridging provided outcomes comparable to non-MCS and may offer a bridge-to-candidacy strategy for selected ECMO patients.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Kim D, Lee KS, Cho YH, et al. Post-transplant outcomes by bridging strategy: A nationwide multicenter study of heart transplant recipients in Korea. J Heart Lung Transplant. 2025. PMID: 41046003. doi:10.1016/j.healun.2025.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。